Leadership Changes in U.S. Preventive Services Task Force

The Trump administration has recently removed the two leading figures of an important health group tasked with deciding when insurance must cover preventive care services. These services include procedures like mammograms and colonoscopies, impacting millions of Americans.

Health Secretary Robert F. Kennedy Jr. sent letters on May 11 to Drs. John Wong and Esa Davis, notifying them of their immediate dismissal from the U.S. Preventive Services Task Force. Their termination came before the completion of their multiyear terms.

Over the past year, the Department of Health and Human Services (HHS) has effectively sidelined the task force by delaying important public meetings. These delays have stalled updates on essential health topics like cervical cancer screenings.

Formed in the 1980s, this panel consists of experts who assess the evidence for various disease prevention tools. These include depression screenings and the use of statins for heart attack prevention. Their guidelines are assigned letter grades, reflecting the strength of the scientific evidence. According to the Affordable Care Act, most insurance plans are required to cover preventive services with an “A” or “B” grade without co-pay.

Kennedy’s letters did not specify reasons for the removal of Wong and Davis. He acknowledged their leadership roles in improving the public’s health and encouraged them to reapply. He noted the review of appointments was intended to ensure clarity, continuity, and confidence in HHS oversight.

The New York Times first reported these leadership changes. An HHS spokesperson did not comment on the reasons behind the dismissals. Kennedy previously informed lawmakers of his plans to reform the task force. He described it as “lackadaisical” and aimed to increase meeting frequency and transparency.

Despite this, the panel conducts public meetings, solicits comments on draft guidelines before finalizing them, and shares the scientific basis for its recommendations. Some health advocates voiced concerns that Kennedy might replace the expert task force with less experienced political appointees, reflecting changes he previously made to a critical vaccine advisory committee.

Dr. Michael Silverstein, a former task force chairman, reported the group was barred from publishing updates to cervical cancer screening guidelines or advancing maternal depression recommendations. He expressed concern about the level of government influence exerted on scientific processes during his decade on the task force.

The task force’s members have staggered terms, allowing health secretaries to make appointments without destabilizing the group, as explained by Aaron Carroll from AcademyHealth, a nonpartisan health policy organization.